Two different classes of therapy-related and de-novo acute myeloid leukemia?
- 1 August 1991
- journal article
- review article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 55 (1), 119-124
- https://doi.org/10.1016/0165-4608(91)90246-q
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumoursThe Lancet, 1991
- Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemiaBlood, 1990
- Secondary Acute Myeloid Leukemia in Children Treated for Acute Lymphoid LeukemiaNew England Journal of Medicine, 1989
- Favorable cytogenetic abnormalities in secondary leukemiaCancer, 1989
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lungBlood, 1987
- RISK OF THERAPY-RELATED LEUKAEMIA AND PRELEUKAEMIA AFTER HODGKIN'S DISEASEThe Lancet, 1987
- The association of specific “favorable” cytogenetic abnormalities with secondary leukemiaCancer, 1986
- Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.Journal of Clinical Oncology, 1986
- Chromosomes and causation of human cancer and leukemia. L. Cytogenetics of leukemias complicating other diseasesCancer Genetics and Cytogenetics, 1982